Dejan Mesner
Impact in
-
- HIV Research and Treatment
-
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Papers in
-
- SARS-CoV-2 and COVID-19 Research 3
- COVID-19 Clinical Research Studies 2
- HIV/AIDS drug development and treatment 1
- Virology 3
- HIV Research and Treatment 3
- Co-authors
- Clare Jolly (6 shared papers)P. Anton van der Merwe (1 shared paper)M. Fairhead (1 shared paper)Mark Howarth (1 shared paper)Jun Yan (1 shared paper)Carol V. Robinson (1 shared paper)Melissa Lever (1 shared paper)Gianluca Veggiani (1 shared paper)
- Journals
- Proceedings of the National Academy of Sciences (2 papers)Cell Reports (2 papers)Journal of the American Chemical Society (1 paper)Viruses (1 paper)Nature Microbiology (1 paper)
- Partner nations
- United KingdomSouth AfricaGermany
In The Last Decade
Dejan Mesner
7 papers receiving 149 citations
Peers
Comparison fields: 5 of 44
- Virology 19
- Infectious Diseases 50
- Immunology 28
- Modeling and Simulation 6
- Radiology, Nuclear Medicine and Imaging 23
Countries citing papers authored by Dejan Mesner
This map shows the geographic impact of Dejan Mesner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dejan Mesner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dejan Mesner more than expected).
Fields of papers citing papers by Dejan Mesner
This network shows the impact of papers produced by Dejan Mesner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dejan Mesner. The network helps show where Dejan Mesner may publish in the future.
Co-authors
The 25 scholars most cited alongside Dejan Mesner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 60 | |
| 2 | 2024 | 37 | |
| 3 | 2023 | 28 | |
| 4 | 2020 | 11 | |
| 5 | 2022 | 9 | |
| 6 | 2022 | 4 | |
| 7 | 2025 | 1 |
About Dejan Mesner
Dejan Mesner is a scholar working on Infectious Diseases, Virology, Epidemiology, Public Health, Environmental and Occupational Health and Radiology, Nuclear Medicine and Imaging, having authored 7 papers that have together received 150 indexed citations. Recurring topics across this work include HIV Research and Treatment (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers), COVID-19 Clinical Research Studies (2 papers), Mosquito-borne diseases and control (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Immune Cell Function and Interaction (2 papers), Viral Infections and Immunology Research (1 paper) and HIV/AIDS drug development and treatment (1 paper). The work is most often cited by research in Virology (19 citations), Infectious Diseases (50 citations), Immunology (28 citations), Modeling and Simulation (6 citations) and Radiology, Nuclear Medicine and Imaging (23 citations). Dejan Mesner has collaborated with scholars based in United Kingdom, South Africa and Germany. Frequent co-authors include Clare Jolly, P. Anton van der Merwe, M. Fairhead, Mark Howarth, Jun Yan, Carol V. Robinson, Melissa Lever, Gianluca Veggiani, Omer Dushek and Ann‐Kathrin Reuschl. Their work appears in journals such as Proceedings of the National Academy of Sciences, Cell Reports, Journal of the American Chemical Society, Viruses and Nature Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.